Skip to main content
. Author manuscript; available in PMC: 2023 Nov 24.
Published in final edited form as: Curr Res Chem Biol. 2023 Sep 22;3:100045. doi: 10.1016/j.crchbi.2023.100045

Fig. 5.

Fig. 5.

a. CL100 screen of denoted cancers by organ to determine IC50 of SGC-CLK-1, b. CCLE quantification of CLK2 peptide abundance (tan boxplot) as compared to IC50 (blue boxplot from 4a) by cancer type, c. ratio of IC50 to CLK2 peptide abundance where a higher score suggests greater CLK2 dependence, d. DepMap and IC50: peptide ratio Venn diagram for overlapping CLK2 dependent cancers.